Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04443010 · RECRUITING
Trial details
- NCT number
- NCT04443010
- Sponsor
- Philogen S.p.A.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2026-10-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.